| pubmed-article:42224 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:42224 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:42224 | lifeskim:mentions | umls-concept:C0341628 | lld:lifeskim |
| pubmed-article:42224 | lifeskim:mentions | umls-concept:C0013072 | lld:lifeskim |
| pubmed-article:42224 | lifeskim:mentions | umls-concept:C0150097 | lld:lifeskim |
| pubmed-article:42224 | lifeskim:mentions | umls-concept:C0010068 | lld:lifeskim |
| pubmed-article:42224 | pubmed:issue | 19 | lld:pubmed |
| pubmed-article:42224 | pubmed:dateCreated | 1980-2-28 | lld:pubmed |
| pubmed-article:42224 | pubmed:abstractText | The effect of mepindolol-sulfate (2 x 2.5 mg) was tested in 20 patients with coronary heart disease in a controlled study against placebo resp. propranolol (3 x 40 mg). Results: 1. The frequency and intensity of anginal attacks were reduced significantly under mepindolol-sulfate therapy.-- 2. There was a significant improvement of ergometric exercise tolerance under mepindolol-sulfate therapy.--3. Additionally a reduction of ST-depression in ECG was found under mepindolol-sulfate.--4. In patients with coronary heart disease the clinical effect of mepindolol-sulfate in a daily dose of 2 x 2.5 mg was equal to propranolol in a daily dose of 3 x 40 mg. | lld:pubmed |
| pubmed-article:42224 | pubmed:language | ger | lld:pubmed |
| pubmed-article:42224 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:42224 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:42224 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:42224 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:42224 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:42224 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:42224 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:42224 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:42224 | pubmed:issn | 0043-5341 | lld:pubmed |
| pubmed-article:42224 | pubmed:author | pubmed-author:KailFF | lld:pubmed |
| pubmed-article:42224 | pubmed:author | pubmed-author:BonelliJJ | lld:pubmed |
| pubmed-article:42224 | pubmed:author | pubmed-author:Magometschnig... | lld:pubmed |
| pubmed-article:42224 | pubmed:author | pubmed-author:KleinbergerGG | lld:pubmed |
| pubmed-article:42224 | pubmed:author | pubmed-author:SchoberHH | lld:pubmed |
| pubmed-article:42224 | pubmed:author | pubmed-author:PichlerHH | lld:pubmed |
| pubmed-article:42224 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:42224 | pubmed:day | 20 | lld:pubmed |
| pubmed-article:42224 | pubmed:volume | 129 | lld:pubmed |
| pubmed-article:42224 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:42224 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:42224 | pubmed:pagination | 541-6 | lld:pubmed |
| pubmed-article:42224 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:42224 | pubmed:meshHeading | pubmed-meshheading:42224-Hu... | lld:pubmed |
| pubmed-article:42224 | pubmed:meshHeading | pubmed-meshheading:42224-Ag... | lld:pubmed |
| pubmed-article:42224 | pubmed:meshHeading | pubmed-meshheading:42224-Pl... | lld:pubmed |
| pubmed-article:42224 | pubmed:meshHeading | pubmed-meshheading:42224-Fe... | lld:pubmed |
| pubmed-article:42224 | pubmed:meshHeading | pubmed-meshheading:42224-Ma... | lld:pubmed |
| pubmed-article:42224 | pubmed:meshHeading | pubmed-meshheading:42224-Co... | lld:pubmed |
| pubmed-article:42224 | pubmed:meshHeading | pubmed-meshheading:42224-My... | lld:pubmed |
| pubmed-article:42224 | pubmed:meshHeading | pubmed-meshheading:42224-Mi... | lld:pubmed |
| pubmed-article:42224 | pubmed:meshHeading | pubmed-meshheading:42224-Do... | lld:pubmed |
| pubmed-article:42224 | pubmed:meshHeading | pubmed-meshheading:42224-Pr... | lld:pubmed |
| pubmed-article:42224 | pubmed:meshHeading | pubmed-meshheading:42224-Dr... | lld:pubmed |
| pubmed-article:42224 | pubmed:meshHeading | pubmed-meshheading:42224-Ad... | lld:pubmed |
| pubmed-article:42224 | pubmed:meshHeading | pubmed-meshheading:42224-Ha... | lld:pubmed |
| pubmed-article:42224 | pubmed:meshHeading | pubmed-meshheading:42224-Pi... | lld:pubmed |
| pubmed-article:42224 | pubmed:year | 1979 | lld:pubmed |
| pubmed-article:42224 | pubmed:articleTitle | [A double blind cross-over study with mepindolol-sulfate in patients with coronary heart disease (author's transl)]. | lld:pubmed |
| pubmed-article:42224 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:42224 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:42224 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:42224 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:42224 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
